Joseph Wright - Merit Medical President - International Division
| MMSI Stock | USD 105.03 0.95 0.91% |
President
Mr. Joseph C. Wright is President International Division of the Company. He is joined the Company in 2005 as Vice President, International, responsible for sales in Canada, Asia Pacific, and Latin America. In 2006. Previous positions at Merit include President, Technology Group overseeing Merit OEM, Merit Sensor Systems, Inc., and Merits coating division, Vice President of Marketing, and Vice President, International responsible for sales in Canada, Asia Pacific, and Latin America, 2005 to 2015. He Manages businesses in all global markets outside the U.S. and EMEA. Before joining Merit, held sales, marketing and business development positions with several companies, including Motorola and Micron. B.A.,, Columbia University M.B.A., Columbia University Speaks Japanese. Mr. Wright is the brotherinlaw of Fred P. Lampropoulos, Merits CEO, President and Chair of the Board since 2015.
| Age | 54 |
| Tenure | 9 years |
| Address | 1600 West Merit Parkway, South Jordan, UT, United States, 84095 |
| Phone | 801 253 1600 |
| Web | https://www.merit.com |
Latest Insider Transactions
Joseph Wright Latest Insider Activity
Tracking and analyzing the buying and selling activities of Joseph Wright against Merit Medical stock is an integral part of due diligence when investing in Merit Medical. Joseph Wright insider activity provides valuable insight into whether Merit Medical is net buyers or sellers over its current business cycle. Note, Merit Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Merit Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Joseph Wright over six months ago Acquisition by Joseph Wright of 300 shares of Peoples Fin subject to Rule 16b-3 | ||
Joseph Wright over a year ago Purchase by Joseph Wright of 2378 shares of Peoples Fin | ||
Joseph Wright over a year ago Acquisition by Joseph Wright of 10183 shares of Merit Medical subject to Rule 16b-3 |
Merit Medical Management Efficiency
The company has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.094 %, meaning that it created $0.094 on every $100 dollars invested by stockholders. Merit Medical's management efficiency ratios could be used to measure how well Merit Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Merit Medical's Return On Capital Employed is increasing as compared to previous years. The Merit Medical's current Return On Assets is estimated to increase to 0.05, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 342.2 M, while Other Assets are projected to decrease to under 25.7 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Raj Sodhi | ResMed Inc | 45 | |
| Gael Touya | AptarGroup | 54 | |
| Holly Sheffield | The Cooper Companies, | 53 | |
| Xiangwei Gong | AptarGroup | 54 | |
| Daniel Woolson | ICU Medical | 47 | |
| David Helsel | AngioDynamics | 60 | |
| Jacqueline Scanlan | Haemonetics | 46 | |
| James Darecca | Haemonetics | 50 | |
| Robert Douglas | ResMed Inc | 64 | |
| Eldon Schaffer | AptarGroup | 53 | |
| Warren Nighan | AngioDynamics | 55 | |
| Ian Bell | Alcon AG | 53 | |
| Patrik Eriksson | Envista Holdings Corp | 56 | |
| Mario Wijker | Teleflex Incorporated | 52 | |
| Kim Seabury | AngioDynamics | 57 | |
| Brian Andrews | The Cooper Companies, | 45 | |
| William Burke | Haemonetics | 52 | |
| Annette Favorite | West Pharmaceutical Services | 59 | |
| SueJean Lin | Alcon AG | 65 | |
| Marc Prieur | AptarGroup | 58 | |
| Stewart Strong | Haemonetics | 57 | |
Management Performance
| Return On Equity | 0.094 | ||||
| Return On Asset | 0.0456 |
Merit Medical Systems Leadership Team
Elected by the shareholders, the Merit Medical's board of directors comprises two types of representatives: Merit Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merit. The board's role is to monitor Merit Medical's management team and ensure that shareholders' interests are well served. Merit Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merit Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fred Lampropoulos, Chairman, CEO and Pres | ||
| CPA Parra, CFO Treasurer | ||
| Sarah Comstock, Vice Communications | ||
| JoAnne Alkire, Executive Strategy | ||
| Joseph Wright, President - International Division | ||
| Neil Peterson, Chief Officer | ||
| Joseph Pierce, Chief Officer | ||
| Nicole Priest, Chief Officer | ||
| Michel Voigt, Chief Officer | ||
| Brian Lloyd, Chief Legal Officer, Corporate Secretary | ||
| Ricardo Alvarez, Managing Tijuana | ||
| John Knorpp, Chief Officer | ||
| Jason Treft, Chief Officer | ||
| Brian JD, Chief Secretary |
Merit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merit Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.094 | ||||
| Return On Asset | 0.0456 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 6.36 B | ||||
| Shares Outstanding | 58.28 M | ||||
| Shares Owned By Insiders | 2.47 % | ||||
| Shares Owned By Institutions | 97.53 % | ||||
| Number Of Shares Shorted | 2.69 M | ||||
| Price To Earning | 956.67 X |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.